Technology platform for innovative small molecule drugs

Design of novel molecules that are non-addictive and non-respiratory depressant.

Technology platform for long-acting microspheres and liposomes

Sustained-release microsphere injections which can provide analgesia and local anesthesia for more than 24 hours after single injection.

Technology platform for transdermal administration

Sufentanil transdermal patch and other products have no first-pass effect and high bioavailability.

Technology platform for anti-abuse design of special drugs

Drugs including Hydrocodone Sustained-release Tablets and Oxycodone Sustained-release Tablets, are designed to be difficult to crush, difficult to extract and difficult to be abused.

Technology platform for oral sustained-release and controlled -release drugs

To make the blood concentration stable and the side effects reduced for hydromorphone sustained-release tablets.

Technology platform for oral mucous administration

Fententanil oral patches and other products are absorbed through mucous membranes and can take effect quickly.

Technology platform for innovative small molecule drugs

Design of novel molecules that are non-addictive and non-respiratory depressant.

Technology platform for long-acting microspheres and liposomes

Sustained-release microsphere injections which can provide analgesia and local anesthesia for more than 24 hours after single injection.

Technology platform for transdermal administration

Sufentanil transdermal patch and other products have no first-pass effect and high bioavailability.

Technology platform for anti-abuse design of special drugs

Drugs including Hydrocodone Sustained-release Tablets and Oxycodone Sustained-release Tablets, are designed to be difficult to crush, difficult to extract and difficult to be abused.

Technology platform for oral sustained-release and controlled -release drugs

To make the blood concentration stable and the side effects reduced for hydromorphone sustained-release tablets.

Technology platform for oral mucous administration

Fententanil oral patches and other products are absorbed through mucous membranes and can take effect quickly.

Technology platform for innovative small molecule drugs

Design of novel molecules that are non-addictive and non-respiratory depressant.

Technology platform for long-acting microspheres and liposomes

Sustained-release microsphere injections which can provide analgesia and local anesthesia for more than 24 hours after single injection.

Technology platform for transdermal administration

Sufentanil transdermal patch and other products have no first-pass effect and high bioavailability.

Technology platform for anti-abuse design of special drugs

Drugs including Hydrocodone Sustained-release Tablets and Oxycodone Sustained-release Tablets, are designed to be difficult to crush, difficult to extract and difficult to be abused.

Technology platform for oral sustained-release and controlled -release drugs

To make the blood concentration stable and the side effects reduced for hydromorphone sustained-release tablets.

Technology platform for oral mucous administration

Fententanil oral patches and other products are absorbed through mucous membranes and can take effect quickly.